483
Lupin Limited (Unit II)FDA 483 - Lupin Limited (Unit II) - December 04, 2018
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Lupin Limited (Unit II) in Mandideep, India, revealed significant deficiencies in manufacturing practices. The firm was cited for inadequate cleaning validation processes for equipment, insufficient performance qualification of water treatment systems, and a lack of proper Quality Unit oversight. Additionally, the inspection found that user access controls for computerized SCADA systems were not adequately defined.
Open in Dashboard
ID · 01157280-eaec-44ff-b43a-16ebb2d2c1c2